These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 3120036)

  • 1. Breakthrough seizure following substitution of Depakene capsules (Abbott) with a generic product.
    MacDonald JT
    Neurology; 1987 Dec; 37(12):1885. PubMed ID: 3120036
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of switching from Depakene to generic valproic acid on individuals with mental retardation.
    Vadney VJ; Kraushaar KW
    Ment Retard; 1997 Dec; 35(6):468-72. PubMed ID: 9425876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Valproic Acid Suppositories for Management of Seizures for Geriatric Patients.
    DiScala SL; Tran NN; Silverman MA
    Consult Pharm; 2016; 31(6):313-9. PubMed ID: 27250072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Valproic acid delayed release (Stavzor).
    Med Lett Drugs Ther; 2009 Apr; 51(1309):27-8. PubMed ID: 19343008
    [No Abstract]   [Full Text] [Related]  

  • 5. Which oral valproic acid formulation is best for my patient?
    Knox JE; Freeland KN
    JAAPA; 2015 Jan; 28(1):21-3. PubMed ID: 25522023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generic substitution in the treatment of epilepsy: case evidence of breakthrough seizures.
    Berg MJ; Gross RA; Tomaszewski KJ; Zingaro WM; Haskins LS
    Neurology; 2008 Aug; 71(7):525-30. PubMed ID: 18695164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paliperidone-associated seizure after discontinuation of sodium valproate: a case report.
    Liang CS; Yang FW; Chiang KT
    J Clin Psychopharmacol; 2011 Apr; 31(2):246-7. PubMed ID: 21364338
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical outcomes associated with brand-to-generic phenytoin interchange.
    Kinikar SA; Delate T; Menaker-Wiener CM; Bentley WH
    Ann Pharmacother; 2012 May; 46(5):650-8. PubMed ID: 22550275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substitution of immediate-release valproic acid for divalproex sodium for adult psychiatric inpatients.
    Sherr JD; Kelly DL
    Psychiatr Serv; 1998 Oct; 49(10):1355-7. PubMed ID: 9779912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-equivalence of bioavailability between generic and branded form of sodium valproate.
    Dhanaraj M; Jayavelu A
    Neurol India; 2004 Sep; 52(3):398. PubMed ID: 15472447
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacokinetics of valproic acid after administration of three oral formulations in healthy adults.
    Bano G; Gupta S; Gupta KL; Raina RK
    J Assoc Physicians India; 1990 Sep; 38(9):629-30. PubMed ID: 2266076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Interaction of valproic acid and erythromycin].
    Sánchez Romero A; Onsurbe Ramírez I
    An Esp Pediatr; 1990 Jan; 32(1):78-9. PubMed ID: 2109560
    [No Abstract]   [Full Text] [Related]  

  • 13. Update on the costs of Depakote and Depakene.
    Feldstein JH; Curtis JL
    Ment Retard; 1995 Feb; 33(1):62. PubMed ID: 7707942
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment with intravenous valproic acid in a newly born].
    Gutiérrez García M; García Benayas E; Pérez Iglesias F; García Díaz B
    Farm Hosp; 2010; 34(5):259-61. PubMed ID: 20347373
    [No Abstract]   [Full Text] [Related]  

  • 15. Increased seizure frequency with generic primidone.
    Wyllie E; Pippenger CE; Rothner AD
    JAMA; 1987 Sep; 258(9):1216-7. PubMed ID: 3626006
    [No Abstract]   [Full Text] [Related]  

  • 16. Biopharmaceutical factors in seizure control and drug toxicity.
    Meyer MC; Straughn AB
    Am J Hosp Pharm; 1993 Dec; 50(12 Suppl 5):S17-22. PubMed ID: 8122697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The use of generic valparin xr in the treatment of epilepsy.].
    Gromov SA; Lipatova LV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2007; 107(10):44-6. PubMed ID: 18477978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Valproic acid.
    Tift JP
    N Engl J Med; 1980 Aug; 303(7):394-5. PubMed ID: 6771651
    [No Abstract]   [Full Text] [Related]  

  • 19. Sodium Valproate as a Continuous Subcutaneous Infusion: A Case Series.
    O'Connor N; Hayden C; O'Leary N
    J Pain Symptom Manage; 2017 Aug; 54(2):e1-e2. PubMed ID: 28433547
    [No Abstract]   [Full Text] [Related]  

  • 20. Loss of seizure control associated with generic substitution of carbamazepine.
    Welty TE; Pickering PR; Hale BC; Arazi R
    Ann Pharmacother; 1992 Jun; 26(6):775-7. PubMed ID: 1611158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.